OPRX Shares Rise 69.3% in 3 Months: Time to Bet on the Stock?

Key Takeaways OPRX Q1 revenues rose 11% to $21.9M, with $3.9M cash flow and raised FY25 guidance. OPRX's contracted revenues grew 25% YoY, now over $70M and 80% of FY25 guidance midpoint. Shift to subscription model is underway, aiding OPRX's margin outlook and revenue stability.OptimizeRx (OPRX) , a digital health platform that connects pharmaceutical companies with healthcare providers and patients, delivered a strong start to fiscal 2025 with first-quarter results that surpassed Wall Street expectation ...